Freeline Therapeutics

-$2.40 (-21.33%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FRLN and other stocks, options, and ETFs commission-free!

About FRLN

Freeline Therapeutics Holdings Plc operates as holding company whose subsidiaries provide biotechnology services. It develops gene therapies for bleeding and other debilitating disorders.

CEO
Theresa Marie Heggie
Employees
235
Headquarters
Stevenage, Hertfordshire
Founded
2015

FRLN Key Statistics

Market Cap
320.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.77K
High Today
$11.62
Low Today
$8.31
Open Price
$11.62
Volume
71.59K
52 Week High
$21.69
52 Week Low
$8.31

FRLN Earnings

Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours

You May Also Like

HAS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure